|
|
News Breaks | | | | January 7, 2013 | | 08:13 EDT |  | INFI | Infinity sees reporting data from both wholly owned clinical programs in 1H13
In the first half of 2013, Infinity expects to report data from both of its wholly owned clinical programs, phosphoinositide-3-kinase and heat shock protein 90, that will inform potential paths to registration. Each program targets areas of unmet patient need such as advanced hematologic malignancies, inflammatory diseases and non-small cell lung cancer. Infinity also announced its second potent, oral PI3K-delta,gamma inhibitor, IPI-443. Nonclinical studies of IPI-443 are now under way, which are designed to enable the initiation of Phase 1 clinical development. Infinity is developing a portfolio of PI3K inhibitors which includes IPI-145 and IPI-443, potent, oral inhibitors of PI3K-delta and PI3K-gamma, as well as retaspimycin hydrochloride, a potent and selective Hsp90 inhibitor. | |
|
News For INFI From The Last 14 Days Check below for free stories on INFI the last two weeks. |
|
|
| May 17, 2013 | | 07:26 EDT |  | INFI | Infinity Pharmaceuticals sell-off excessive, says Wells Fargo
 Subscribe for More Information | | | May 16, 2013 | | 12:07 EDT |  | INFI | Options with increasing implied volatility: INFI WCRX SODA LYV HYG
| | | 12:00 EDT |  | INFI | Infinity Pharmaceuticals falls 19.5%
Subscribe for More Information | | | 07:29 EDT |  | INFI | Leerink to host a bus tour
Boston Biopharma Bus Tour travels throughout Boston on May 16-17. | | | May 9, 2013 | | 10:08 EDT |  | INFI | On The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Chicago Bridge & Iron (CBI) initiated with a Buy at Deutsche Bank... Fluor (FLR) initiated with a Buy at Deutsche Bank... Infinity Pharmaceuticals (INFI) initiated with an Outperform at Wells Fargo... Jacobs Engineering (JEC) initiated with a Hold at Deutsche Bank... KBR (KBR) initiated with a Buy at Deutsche Bank... MasTec (MTZ) initiated with a Buy at Deutsche Bank... McDermott (MDR) initiated with a Hold at Deutsche Bank... Merit Medical (MMSI) initiated with a Hold at Benchmark Co... Ocean Power (OPTT) initiated with a Strong Buy at Ascendiant Capital... Quanta Services (PWR) initiated with a Buy at Deutsche Bank... ZELTIQ Aesthetics (ZLTQ) initiated with a Buy at Maxim... Evercore Partners (EVR) initiated with a Positive at Susquehanna... Alexander & Baldwin (ALEX) initiated with an Outperform at JMP Securities... Myriad Genetics (MYGN) coverage resumed with an Overweight at Stephens... Pinnacle Foods (PF) initiated with a Buy at Janney Capital. | | | 05:38 EDT | | INFI | Infinity Pharmaceuticals initiated with an Outperform at Wells Fargo
Price target range $48-$50. | |
|
|
|
|
|
|
